| Audio Interview: Tocilizumab and Covid-19 #MMPMID33085870Rubin EJ; Baden LR; Morrissey SN Engl J Med 2020[Oct]; 383 (17): e114 PMID33085870show ga
ä|Anti-Inflammatory Agents/*therapeutic use[MESH]|Antibodies, Monoclonal, Humanized/*therapeutic use[MESH]|Betacoronavirus/drug effects/*pathogenicity/physiology[MESH]|COVID-19[MESH]|COVID-19 Drug Treatment[MESH]|Confidence Intervals[MESH]|Coronavirus Infections/*drug therapy/immunology/virology[MESH]|Dexamethasone/therapeutic use[MESH]|Glucocorticoids/therapeutic use[MESH]|Humans[MESH]|Inflammation/drug therapy[MESH]|Interleukin-6/blood[MESH]|Pandemics[MESH]|Pneumonia, Viral/*drug therapy/immunology/virology[MESH]|Respiratory Distress Syndrome/virology[MESH]|SARS-CoV-2[MESH]|Treatment Failure[MESH]
DeepDyve Pubget Overpricing |
|